Skip to content

Drug interactions

Bortezomib + Eslicarbazepine

Severity: Minor

Bortezomib and Eslicarbazepine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eslicarbazepine is a weak CYP3A4 inducer and may modestly lower bortezomib exposure. Bortezomib is metabolized by CYP3A4, 2C19 and 1A2, so the net effect is uncertain.

What this interaction means in plain words

Bortezomib and Eslicarbazepine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Bortezomib belongs to Oncology; Eslicarbazepine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Weak CYP3A4 induction by eslicarbazepine may increase bortezomib metabolism; net effect is not well established.

What to do

Monitor response and toxicity to bortezomib; no empiric dose change is needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Bortezomib and Eslicarbazepine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Bortezomib with Eslicarbazepine?

MediHelp rates the interaction as minor. Bortezomib and Eslicarbazepine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Eslicarbazepine is a weak CYP3A4 inducer and may modestly lower bortezomib exposure. Bortezomib is metabolized by CYP3A4, 2C19 and 1A2, so the net effect is uncertain.

How serious is the interaction between Bortezomib and Eslicarbazepine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor response and toxicity to bortezomib; no empiric dose change is needed.

What other medicines interact with Eslicarbazepine?

MediHelp also lists interactions of Eslicarbazepine with, for example, Mavacamten, Rilpivirine, Artemether / lumefantrine. The full list is on the Eslicarbazepine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in